114 related articles for article (PubMed ID: 16766467)
21. DEVELOPMENT AND EVALUATION OF IVABRADINE HCI-LOADED POLYMERIC MICROSPHERES PREPARED WITH EUDRAGIT L100-55 (METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER) AND ETHYL CELLULOSE FOR CONTROLLED DRUG RELEASE.
Majeed A; Ranjha NM; Hanif M; Abbas G; Khan MA
Acta Pol Pharm; 2017 Mar; 74(2):565-578. PubMed ID: 29624261
[TBL] [Abstract][Full Text] [Related]
22. Core/shell cellulose-based microspheres for oral administration of Ketoprofen Lysinate.
Guarino V; Caputo T; Calcagnile P; Altobelli R; Demitri C; Ambrosio L
J Biomed Mater Res B Appl Biomater; 2018 Oct; 106(7):2636-2644. PubMed ID: 29377599
[TBL] [Abstract][Full Text] [Related]
23. Novel pH-sensitive blend microspheres for controlled release of nifedipine--an antihypertensive drug.
Phadke KV; Manjeshwar LS; Aminabhavi TM
Int J Biol Macromol; 2015 Apr; 75():505-14. PubMed ID: 25647620
[TBL] [Abstract][Full Text] [Related]
24. Design and evaluation of temperature-responsive chitosan/hydroxypropyl cellulose blend nanospheres for sustainable flurbiprofen release.
Işıklan N; Erol ÜH
Int J Biol Macromol; 2020 Sep; 159():751-762. PubMed ID: 32416307
[TBL] [Abstract][Full Text] [Related]
25. Chitosan microspheres prepared by spray drying.
He P; Davis SS; Illum L
Int J Pharm; 1999 Sep; 187(1):53-65. PubMed ID: 10502613
[TBL] [Abstract][Full Text] [Related]
26. Controlled release chitosan microspheres of mirtazapine: in vitro and in vivo evaluation.
Ranjan OP; Shavi GV; Nayak UY; Arumugam K; Averineni RK; Meka SR; Sureshwar P
Arch Pharm Res; 2011 Nov; 34(11):1919-29. PubMed ID: 22139691
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of genipin-cross-linked silk fibroin/chitosan sustained-release microspheres.
Zeng S; Ye M; Qiu J; Fang W; Rong M; Guo Z; Gao W
Drug Des Devel Ther; 2015; 9():2501-14. PubMed ID: 25999693
[TBL] [Abstract][Full Text] [Related]
28. Fabrication of the polyphosphates patched cellulose sulfate-chitosan hydrochloride microcapsules and as vehicles for sustained drug release.
Su T; Wu QX; Chen Y; Zhao J; Cheng XD; Chen J
Int J Pharm; 2019 Jan; 555():291-302. PubMed ID: 30471376
[TBL] [Abstract][Full Text] [Related]
29. Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug.
Wang LY; Ma GH; Su ZG
J Control Release; 2005 Aug; 106(1-2):62-75. PubMed ID: 15922472
[TBL] [Abstract][Full Text] [Related]
30. Spray-dried chitosan/ethylcellulose microspheres for nasal drug delivery: swelling study and evaluation of in vitro drug release properties.
Martinac A; Filipović-Grcić J; Perissutti B; Voinovich D; Pavelić Z
J Microencapsul; 2005 Aug; 22(5):549-61. PubMed ID: 16361198
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo evaluation of ranitidine hydrochloride loaded hollow microspheres in rabbits.
Wei YM; Zhao L
Arch Pharm Res; 2008 Oct; 31(10):1369-77. PubMed ID: 18958430
[TBL] [Abstract][Full Text] [Related]
32. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
33. Screening of ionically crosslinked chitosan-tripolyphosphate microspheres using Plackett-Burman factorial design for the treatment of intrapocket infections.
Yadav SK; Khan G; Bansal M; Vardhan H; Mishra B
Drug Dev Ind Pharm; 2017 Nov; 43(11):1801-1816. PubMed ID: 28673095
[TBL] [Abstract][Full Text] [Related]
34. Controlled delivery of the popular nonsteroidal anti-inflammatory drug, paracetamol, from chitosan-g-polyacrylamide microspheres prepared by the emulsion crosslinking technique.
Bulut E
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1482-90. PubMed ID: 25985724
[TBL] [Abstract][Full Text] [Related]
35. Preparation of aerogel beads and microspheres based on chitosan and cellulose for drug delivery: A review.
Shi W; Ching YC; Chuah CH
Int J Biol Macromol; 2021 Feb; 170():751-767. PubMed ID: 33412201
[TBL] [Abstract][Full Text] [Related]
36. Chitosan microspheres of aceclofenac: in vitro and in vivo evaluation.
Nagda C; Chotai N; Patel S; Nagda D; Patel U; Soni T
Pharm Dev Technol; 2010; 15(5):442-51. PubMed ID: 20735299
[TBL] [Abstract][Full Text] [Related]
37. Preparation and drug release properties of chitosan/organomodified palygorskite microspheres.
Wu J; Ding S; Chen J; Zhou S; Ding H
Int J Biol Macromol; 2014 Jul; 68():107-12. PubMed ID: 24769084
[TBL] [Abstract][Full Text] [Related]
38. Development and characterization of chitosan succinate microspheres for the improved oral bioavailability of insulin.
Ubaidulla U; Khar RK; Ahmad FJ; Sultana Y; Panda AK
J Pharm Sci; 2007 Nov; 96(11):3010-23. PubMed ID: 17588259
[TBL] [Abstract][Full Text] [Related]
39. Influence of chitosan coating on the liposomal surface on physicochemical properties and the release profile of nanocarrier systems.
Bang SH; Hwang IC; Yu YM; Kwon HR; Kim DH; Park HJ
J Microencapsul; 2011; 28(7):595-604. PubMed ID: 21861589
[TBL] [Abstract][Full Text] [Related]
40. Preparation of Eudragit E100 microspheres by modified solvent evaporation method.
Singh V; Chaudhary AK
Acta Pol Pharm; 2011; 68(6):975-80. PubMed ID: 22125964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
